Efficiency of intracavernosal alprostadil and oral clomiphene citrate combination treatment in penile vasculogenic erectile dysfunction patients accompanied by late‐onset hypogonadism

Andrologia ◽  
2020 ◽  
Vol 52 (10) ◽  
Author(s):  
Hakan Hakkı Taşkapu ◽  
Mehmet Giray Sönmez ◽  
Muzaffer Tansel Kılınç ◽  
Nurullah Altınkaya ◽  
Arif Aydın ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Combination Treatment ◽  
Late Onset ◽  
Clomiphene Citrate ◽  
Late Onset Hypogonadism ◽  
Vasculogenic Erectile Dysfunction

Erectile dysfunction as a marker of renal function deterioration in type 2 diabetes male patients with late onset hypogonadism

2011 ◽  
Vol 8 (3) ◽  
pp. 231-231
Author(s):  
V. Luchytskiy ◽  
V. Rybalchenko ◽  
E. Luchytskiy ◽  
G. Zubkova ◽  
Y. Zasieda
Keyword(s):  
Type 2 Diabetes ◽  
Renal Function ◽  
Erectile Dysfunction ◽  
Late Onset ◽  
Renal Function Deterioration ◽  
Male Patients ◽  
Late Onset Hypogonadism

Sexual health

2013 ◽  
pp. 567-602
Author(s):  
John Reynard ◽  
Simon Brewster ◽  
Suzanne Biers
Keyword(s):  
Erectile Dysfunction ◽  
Hormone Replacement Therapy ◽  
Sexual Health ◽  
Replacement Therapy ◽  
Premature Ejaculation ◽  
Late Onset ◽  
Hormone Replacement ◽  
Late Onset Hypogonadism ◽  
Erectile Dysfunction Treatment ◽  
Male Hormone

Physiology of erection and ejaculation 568 Erectile dysfunction: evaluation 572 Erectile dysfunction: treatment 576 Peyronie’s disease 580 Priapism 584 Retrograde ejaculation 588 Premature ejaculation 590 Other disorders of ejaculation and orgasm 592 Late-onset hypogonadism (LOH) 594 Hypogonadism and male hormone replacement therapy 596 Urethritis 600...

scholarly journals Late-Onset Hypogonadism in Latvia

2016 ◽  
Vol 9 (1) ◽  
pp. 164-164
Author(s):  
A. Pozarskis ◽  
◽  
J. Pozarska ◽  
J. Erenpreiss ◽  
◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Blood Serum ◽  
Testosterone Level ◽  
Rating Scale ◽  
Late Onset ◽  
Free Testosterone ◽  
Family Doctors ◽  
Late Onset Hypogonadism ◽  
Free Testosterone Level ◽  
Check Level

Objective: The aim of this study was to examine how common is LOH in Latvian men and to determine the target audience that needs screening for LOH. Design and Method: 300 men over the age of 40 who came to their family doctors and to sexologists were asked to complete the questionnaires for Aging Male Symptoms Rating Scale. Men were divided in three groups based on their age: 40-49 years old, 50-59 years old, and >59 years old. The men who according to the AMS questionnaires had suspicion of LOH symptoms were asked to check their level of testosterone in the blood serum. The authors also have summarized the data on the spread of different chronic diseases among the men. Results: 134 men were asked to check level of testosterone in the blood serum. 29% of men appeared to have hypogonadism. 38% of this men appeared to have adiposity, 77% - hypertension, 18% – diabetes, 51% – dislipidemia, 66%– erectile dysfunction. Among men with normal testosterone level adiposity was found in 29%, hypertension-in 56%, diabetes-in 5%, dislipidemia-in 39%, erectile dysfunction-in 61%. Significantly in hypogonadal men in the group 50-59 years was more frequent hypertension, and in all groups – diabetes mellitus. Conclusions: 1/3 of men aged 40 and older have diagnosis of LOH in the groups under research. It is necessary to check testosterone and free testosterone level: in all men 50-59 years old with arterial hypertension; in all men over the age of 40 with diabetes.

scholarly journals Clomiphene citrate treatment for late onset hypogonadism: rise and fall

2016 ◽  
Vol 42 (6) ◽  
pp. 1190-1194 ◽  
Author(s):  
Marcelo Marconi ◽  
Renato Souper ◽  
Jonathan Hartmann ◽  
Matías Alvarez ◽  
Ignacio Fuentes ◽  
...  
Keyword(s):  
Late Onset ◽  
Clomiphene Citrate ◽  
Late Onset Hypogonadism

1380 THE EFFECTIVENESS OF CLOMIPHENE CITRATE THERAPY FOR LATE-ONSET HYPOGONADISM(LOH)

2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Toshihiro Tai ◽  
Koichi Nagao ◽  
Koichi Nakajima ◽  
Takao Ishiwatari ◽  
Yusuke Oka ◽  
...  
Keyword(s):  
Late Onset ◽  
Clomiphene Citrate ◽  
Late Onset Hypogonadism

scholarly journals Is there a relationship between the severity of erectile dysfunction and the comorbidity profile in men with late onset hypogonadism?

2015 ◽  
Vol 13 (3) ◽  
pp. 162-168 ◽  
Author(s):  
Aksam A. Yassin ◽  
Joanne E. Nettleship ◽  
Yousef Almehmadi ◽  
Dany-Jan Yassin ◽  
Youssef El Douaihy ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Late Onset ◽  
Late Onset Hypogonadism ◽  
Severity Of Erectile Dysfunction ◽  
Comorbidity Profile

Combination treatment with low intensity extracorporeal shock waves and PDE5 inhibitors for vasculogenic erectile dysfunction: a comparative study

2019 ◽  
Vol 18 (12) ◽  
pp. e3628-e3629
Author(s):  
Bochorishvili Aleksandre ◽  
Dzneladze Andro ◽  
Hanna Milad ◽  
Archvadze Nino ◽  
Botchorishvili George
Keyword(s):  
Erectile Dysfunction ◽  
Shock Waves ◽  
Comparative Study ◽  
Combination Treatment ◽  
Pde5 Inhibitors ◽  
Low Intensity ◽  
Extracorporeal Shock Waves ◽  
Vasculogenic Erectile Dysfunction

scholarly journals Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction

Antioxidants ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 837
Author(s):  
Shubhadeep Roychoudhury ◽  
Saptaparna Chakraborty ◽  
Arun Paul Choudhury ◽  
Anandan Das ◽  
Niraj Kumar Jha ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Erectile Dysfunction ◽  
Environmental Factors ◽  
Late Onset ◽  
Scientific Information ◽  
Endocrine Disrupting Chemicals ◽  
Serum Testosterone ◽  
Therapeutic Interventions ◽  
Oxidative Stresses ◽  
Late Onset Hypogonadism

Hypogonadism is an endocrine disorder characterized by inadequate serum testosterone production by the Leydig cells of the testis. It is triggered by alterations in the hypothalamic–pituitary–gonadal axis. Erectile dysfunction (ED) is another common disorder in men that involves an alteration in erectile response–organic, relational, or psychological. The incidence of hypogonadism and ED is common in men aged over 40 years. Hypogonadism (including late-onset hypogonadism) and ED may be linked to several environmental factors-induced oxidative stresses. The factors mainly include exposure to pesticides, radiation, air pollution, heavy metals and other endocrine-disrupting chemicals. These environmental risk factors may induce oxidative stress and lead to hormonal dysfunctions. To better understand the subject, the study used many keywords, including “hypogonadism”, “late-onset hypogonadism”, “testosterone”, “erectile dysfunction”, “reactive oxygen species”, “oxidative stress”, and “environmental pollution” in major online databases, such as SCOPUS and PUBMED to extract relevant scientific information. Based on these parameters, this review summarizes a comprehensive insight into the important environmental issues that may have a direct or indirect association with hypogonadism and ED in men. The study concludes that environmental factors-induced oxidative stress may cause infertility in men. The hypothesis and outcomes were reviewed critically, and the mechanistic approaches are applied through oxidant-sensitive pathways. This study also provides reccomendations on future therapeutic interventions and protective measures against such adverse environmental factors-induced hypogonadism and ED.

Sign in / Sign up

Export Citation Format

Share Document